Stocks and Investing
Stocks and Investing
Fri, November 11, 2022
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
[ Fri, Nov 11th 2022
] - WOPRAI
Geulah Livshits Maintained (TNYA) at Strong Buy with Decreased Target to $28 on, Nov 11th, 2022
Geulah Livshits of Chardan Capital, Maintained "Tenaya Therapeutics, Inc." (TNYA) at Strong Buy with Decreased Target from $30 to $28 on, Nov 11th, 2022.
Geulah has made no other calls on TNYA in the last 4 months.
There is 1 other peer that has a rating on TNYA. Out of the 1 peers that are also analyzing TNYA, 0 agree with Geulah's Rating of Hold.
This is the rating of the analyst that currently disagrees with Geulah
- Whitney Ijem of "Canaccord Genuity" Initiated at Strong Buy and Held Target at $21 on, Tuesday, November 8th, 2022
Contributing Sources